Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
VNRX-5133
DRUG
2 trials
Sponsors
Venatorx Pharmaceuticals, Inc.
Conditions
Bacterial Infections
Phase 1
VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers
Completed
NCT02955459
Venatorx Pharmaceuticals, Inc.
Bacterial Infections
Start: 2016-11-30
End: 2017-06-30
Updated: 2017-07-21
VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers
Completed
NCT03332732
Venatorx Pharmaceuticals, Inc.
Bacterial Infections
Start: 2017-10-24
End: 2017-12-20
Updated: 2018-10-18
Related Papers
Safety and Pharmacokinetics in Human Volunteers of Taniborbactam (VNRX-5133), a Novel Intravenous β-Lactamase Inhibitor.
2021-08-09
31 citations